Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (15)

1

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

enthalten in: Cancers | 2019

von Faraoni, I. | Consalvo, M. | Aloisio, F. | +12

2

6-Thioguanine and Its Analogs Promote Apoptosis of Castration-Resistant Prostate Cancer Cells in a BRCA2-Dependent Manner

enthalten in: Cancers | 2019

von Laera, L. | Guaragnella, N. | Giannattasio, S. | +1

3

Tailoring Ovarian Cancer Treatment : Implications of BRCA1/2 Mutations

enthalten in: Cancers | 2019

von Madariaga, A. | Lheureux, S. | Oza, A.

4

BRCA2 and Other DDR Genes in Prostate Cancer

enthalten in: Cancers | 2019

von Nombela, P. | Lozano, R. | Aytes, A. | +3

5

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells

enthalten in: Cancers | 2019

von Pulliam, N. | Tang, J. | Wang, W. | +6

6

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

in: Cancers | 2019

von Isabella Faraoni | Maria Irno Consalvo | Francesca Aloisio | +12

7

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells

in: Cancers | 2019

von Nicholas Pulliam | Jessica Tang | Weini Wang | +6

8

Tailoring Ovarian Cancer Treatment: Implications of

in: Cancers | 2019

von Ainhoa Madariaga | Stephanie Lheureux | Amit M. Oza

9

Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors

enthalten in: Cancers | 2018

von Faraoni, I. | Graziani, G.

10

Sensitization of Cancer Cells to Radiation and Topoisomerase I Inhibitor Camptothecin Using Inhibitors of PARP and Other Signaling Molecules

enthalten in: Cancers | 2018

von Matsuno, Y. | Hyodo, M. | Fujimori, H. | +2